«The new animal model opens the door for scientists to conduct
needed mechanistic studies and identify preventative therapies to minimize this painful and debilitating condition,» Banga said.
They go on to say that «since no single broadly neutralizing antibody combines the entire range of
mechanistic features anticipated to support in vivo efficacy, our
study adds further evidence that combinations of such antibodies
need to be considered for human application.»